---
title: "Breast Implant Exposure Linked to Reduced Breast Cancer Cell Viability via Antibody-Mediated Immun"
id: "pubmed-41491621"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-41491621"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/41491621/"
doi: "10.1093/asj/sjaf202"
published_at: "2026-09-16T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Breast Implant Exposure Linked to Reduced Breast Cancer Cell Viability via Antibody-Mediated Immun
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-41491621
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/41491621/)
- **DOI:** [10.1093/asj/sjaf202](https://doi.org/10.1093%2Fasj%2Fsjaf202)
- **Published At:** 2026-09-16T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Epidemiologic and preclinical data suggest breast implants may have a protective effect against breast cancer; the mechanism is not established. - Authors hypothesized that local inflammation from **breast implants** enhances systemic **immunosurveillance** and alters serum activity against tumor cells. - The study compared peripheral serum from implant-exposed (IE) and implant-naive (IN) women in vitro using breast cancer cell lines overexpressing targeted antigens. - Three tumor cell lines were used: MCF7 (estrogen receptor–alpha), T47D (mucin-1), and SKBR3 (mammaglobin-A). - Serum was stratified by high or low antibody levels against estrogen receptor–alpha, mucin-1, or mammaglobin-A; 12 samples per cell line were tested, 36 patients total enrolled. - Cell viability was measured with **MTT assays** after incubation with patient serum. - Serum with high antibody concentrations reduced cancer cell viability compared with low-antibody serum across all three cell lines. - Peripheral serum from IE women decreased cell viability compared with serum from IN women across all cell lines, even when samples were matched for antibody levels. - Rescue experiments using recombinant antigen to neutralize antibodies reversed the viability differences between high- and low-antibody serum and between IE and IN serum, implicating **antibodies** as mediators. - Findings imply implant exposure altered antibody function or other serum components beyond antibody concentration. - Authors conclude that the inflammatory response to implants may increase breast cancer immunosurveillance but state that further work is required to confirm mechanisms and clinical relevance.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/41491621/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F41491621%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/41491621/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/41491621/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/41491621/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/c24ab723-7c80-48cd-9c68-022ded852586/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/41491621/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/41491621/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F41491621%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F41491621%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/41491621/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/41491621/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/41491621/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/41491621/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Silverchair Information Systems full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--academic.oup.com-images-oup_pubmed.png) Silverchair Information Systems ](https://academic.oup.com/asj/article-lookup/doi/10.1093/asj/sjaf202 "See full text options at Silverchair Information Systems") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/41491621/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/41491621/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/41491621/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/41491621/#abstract) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/41491621/#similar) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/41491621/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/41491621/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/41491621/#related-links) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/41491621/#grants) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/41491621/#linkout) Title & authors Abstract Similar articles MeSH terms Substances Related information Grants and funding LinkOut - more resources Aesthet Surg J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aesthet+Surg+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Aesthet+Surg+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) . 2026 Sep 16;46(10):1062-1067. doi: 10.1093/asj/sjaf202. # Peripheral Serum From Breast Implant-Exposed Patients Decreases Breast Cancer Cell Viability: Evidence for Immunosurveillance [Puja Jagasia](https://pubmed.ncbi.nlm.nih.gov/?term=Jagasia+P&cauthor_id=41491621), [Mariana Eduardo](https://pubmed.ncbi.nlm.nih.gov/?term=Eduardo+M&cauthor_id=41491621), [Meryl Pearl Franco](https://pubmed.ncbi.nlm.nih.gov/?term=Franco+MP&cauthor_id=41491621), [Joshua DeYoung](https://pubmed.ncbi.nlm.nih.gov/?term=DeYoung+J&cauthor_id=41491621), [David Dolivo](https://pubmed.ncbi.nlm.nih.gov/?term=Dolivo+D&cauthor_id=41491621), [Seok Hong](https://pubmed.ncbi.nlm.nih.gov/?term=Hong+S&cauthor_id=41491621), [Robert Galiano](https://pubmed.ncbi.nlm.nih.gov/?term=Galiano+R&cauthor_id=41491621), [Susan Clare](https://pubmed.ncbi.nlm.nih.gov/?term=Clare+S&cauthor_id=41491621), [Seema Khan](https://pubmed.ncbi.nlm.nih.gov/?term=Khan+S&cauthor_id=41491621), [John Y S Kim](https://pubmed.ncbi.nlm.nih.gov/?term=Kim+JYS&cauthor_id=41491621), [Megan E Fracol](https://pubmed.ncbi.nlm.nih.gov/?term=Fracol+ME&cauthor_id=41491621) * PMID: **41491621** * DOI: [ 10.1093/asj/sjaf202 ](https://doi.org/10.1093/asj/sjaf202) Item in Clipboard # Peripheral Serum From Breast Implant-Exposed Patients Decreases Breast Cancer Cell Viability: Evidence for Immunosurveillance Puja Jagasia et al. Aesthet Surg J. 2026. Show details Display options Display options Format Abstract PubMed PMID Aesthet Surg J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aesthet+Surg+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Aesthet+Surg+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) . 2026 Sep 16;46(10):1062-1067. doi: 10.1093/asj/sjaf202. ### Authors [Puja Jagasia](https://pubmed.ncbi.nlm.nih.gov/?term=Jagasia+P&cauthor_id=41491621), [Mariana Eduardo](https://pubmed.ncbi.nlm.nih.gov/?term=Eduardo+M&cauthor_id=41491621), [Meryl Pearl Franco](https://pubmed.ncbi.nlm.nih.gov/?term=Franco+MP&cauthor_id=41491621), [Joshua DeYoung](https://pubmed.ncbi.nlm.nih.gov/?term=DeYoung+J&cauthor_id=41491621), [David Dolivo](https://pubmed.ncbi.nlm.nih.gov/?term=Dolivo+D&cauthor_id=41491621), [Seok Hong](https://pubmed.ncbi.nlm.nih.gov/?term=Hong+S&cauthor_id=41491621), [Robert Galiano](https://pubmed.ncbi.nlm.nih.gov/?term=Galiano+R&cauthor_id=41491621), [Susan Clare](https://pubmed.ncbi.nlm.nih.gov/?term=Clare+S&cauthor_id=41491621), [Seema Khan](https://pubmed.ncbi.nlm.nih.gov/?term=Khan+S&cauthor_id=41491621), [John Y S Kim](https://pubmed.ncbi.nlm.nih.gov/?term=Kim+JYS&cauthor_id=41491621), [Megan E Fracol](https://pubmed.ncbi.nlm.nih.gov/?term=Fracol+ME&cauthor_id=41491621) * PMID: **41491621** * DOI: [ 10.1093/asj/sjaf202 ](https://doi.org/10.1093/asj/sjaf202) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID ## Abstract Epidemiologic and preclinical studies suggest a potential protective effect of breast implants against breast cancer, but underlying mechanisms remain unclear. The authors hypothesize that local inflammation after breast implant placement induces immunosurveillence. The authors of this study investigated whether serum from implant-exposed (IE) women reduced breast cancer cell viability compared with implant-naive (IN) women, and whether antibodies mediated this effect. Serum from IE and IN women with high or low antibody levels against estrogen receptor-alpha, mucin-1, or mammaglobin-A was incubated with cancer cell lines overexpressing each antigen (MCF7, T47D, and SKBR3, respectively). 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assays measured cell viability. Rescue experiments utilized recombinant antigen to neutralize antibodies. Thirty-six patients were enrolled, and 12 samples were used to assess viability for each cell line. Serum with high antibody concentrations reduced cell viability compared with serum with low antibody concentrations across all cell lines. IE serum reduced cell viability compared with IN serum across all cell lines. Rescue experiments reversed differences between high and low antibody serum, as well as between IE and IN serum, implicating antibodies as the mediators of reduced viability. Peripheral serum from IE women decreased breast cancer cell viability compared with IN women, even when matched for the same antibody levels. Antibody neutralization reversed differences. This suggests implant exposure altered antibody function or other serum components. These findings support the hypothesis that the inflammatory response to breast implants may increase breast cancer immunosurveillance, although significantly more work is needed to confirm a mechanism. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text. © The Author(s) 2026. Published by Oxford University Press on behalf of The Aesthetic Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Similar articles * [ Exploring the promising therapeutic benefits of iodine and radioiodine in breast cancer cell lines. ](https://pubmed.ncbi.nlm.nih.gov/39816086/) Elliyanti A, Hafizhah N, Salsabila D, Susilo VY, Setiyowati S, Tofrizal A, Kurniawati Y, Irrahmah M.Elliyanti A, et al.Narra J. 2024 Dec;4(3):e1078. doi: 10.52225/narra.v4i3.1078. Epub 2024 Dec 2.Narra J. 2024.PMID: 39816086Free PMC article. * [ Cells and Shells: Investigating How Breast Implant Shells Negatively Impact Cell Viability In Vitro. ](https://pubmed.ncbi.nlm.nih.gov/40888286/) Salingaros S, Jeon J, Fuchsman AC, Dong X, Spector JA.Salingaros S, et al.J Biomed Mater Res B Appl Biomater. 2025 Sep;113(9):e35649. doi: 10.1002/jbm.b.35649.J Biomed Mater Res B Appl Biomater. 2025.PMID: 40888286 * [ Comparative EPR Studies on the Influence of Genistein on Free Radicals in Non-Irradiated and UV-Irradiated MCF7, T47D and MDA-MB-231 Breast Cancer Cells. ](https://pubmed.ncbi.nlm.nih.gov/38540131/) Jurzak M, Ramos P, Pilawa B, Bednarek IA.Jurzak M, et al.Biomedicines. 2024 Feb 26;12(3):518. doi: 10.3390/biomedicines12030518.Biomedicines. 2024.PMID: 38540131Free PMC article. * [ Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. ](https://pubmed.ncbi.nlm.nih.gov/36321557/) Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.Crider K, et al.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.Cochrane Database Syst Rev. 2022.Update in: [Cochrane Database Syst Rev. 2026 Feb 18;2:CD014217. doi: 10.1002/14651858.CD014217.pub2.](https://pubmed.ncbi.nlm.nih.gov/41705996/)PMID: 36321557Free PMC article.Updated. * [ Different types of implants for reconstructive breast surgery. ](https://pubmed.ncbi.nlm.nih.gov/27182693/) Rocco N, Rispoli C, Moja L, Amato B, Iannone L, Testa S, Spano A, Catanuto G, Accurso A, Nava MB.Rocco N, et al.Cochrane Database Syst Rev. 2016 May 16;2016(5):CD010895. doi: 10.1002/14651858.CD010895.pub2.Cochrane Database Syst Rev. 2016.PMID: 27182693Free PMC article. [ See all similar articles ](https://pubmed.ncbi.nlm.nih.gov/?linkname=pubmed_pubmed&from_uid=41491621) ## MeSH terms * Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Breast Implantation* / adverse effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Breast+Implantation%2Fadverse+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Breast+Implantation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Breast Implantation* / instrumentation Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Breast+Implantation%2Finstrumentation%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Breast+Implantation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Breast Implants* / adverse effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Breast+Implants%2Fadverse+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Breast+Implants) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Breast Neoplasms* / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Breast+Neoplasms%2Fblood%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Breast+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Breast Neoplasms* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Breast+Neoplasms%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Breast+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Breast Neoplasms* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Breast+Neoplasms%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Breast+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Cell Line, Tumor Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell+Line%2C+Tumor%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell+Line%2C+Tumor) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Cell Survival / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell+Survival%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell+Survival) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Estrogen Receptor alpha / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Estrogen+Receptor+alpha%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Estrogen+Receptor+alpha) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Immunologic Surveillance* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Immunologic+Surveillance%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Immunologic+Surveillance) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * MCF-7 Cells Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22MCF-7+Cells%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=MCF-7+Cells) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Mammaglobin A / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mammaglobin+A%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mammaglobin+A) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Middle Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Middle+Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Middle+Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Monitoring, Immunologic / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Monitoring%2C+Immunologic%2Fmethods%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Monitoring%2C+Immunologic) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/41491621/) * Mucin-1 / immunology
## Related Clinical Research

- [Multimodal Japanese-style acupuncture and moxibustion for taxane-related CIPN in breast cancer sur](https://medichelpline.com/clinical-feed/pubmed-42768220.md) (DOI: 10.1007/s00520-026-11237-1)
- [Sen. Warren demands access to Trump drug-pricing contracts, accuses RFK Jr. of concealing them](https://medichelpline.com/clinical-feed/stat-news-0-stat-sen-warren-demands-to-see-trump-drug-pricing-pharma-contracts-accuses-rfk.md)
- [FDA pilot to speed human testing and Montana’s private board expands access to experimental drugs](https://medichelpline.com/clinical-feed/stat-news-1-stat-pharmalittle-we-re-reading-about-faster-fda-approvals-access-to.md)
- [EV-encapsulated miRNAs drive monocyte–endothelial crosstalk and worsen renal injury in diabetic ki](https://medichelpline.com/clinical-feed/pubmed-42275918.md) (DOI: 10.1016/j.intimp.2026.116960)
- [Participation in a low‑intensity health assessment program linked to lower diabetes risk in older](https://medichelpline.com/clinical-feed/plos-medicine-0-association-of-a-multiple-risk-factor-assessment-and-intervention-program-with.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.